The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

  • See Evidence submitted by expert panel for details.

CA16020742

Gene: PAH
Condition: phenylketonuria
Inheritance Mode: Autosomal recessive inheritance
UUID: 537c252b-458c-4470-b4cf-41cce415c4bf

HGVS expressions

NM_000277.3:c.190_194del
NC_000012.12:g.102894893_102894897del
CM000674.2:g.102894893_102894897del
NC_000012.11:g.103288671_103288675del
CM000674.1:g.103288671_103288675del
NC_000012.10:g.101812801_101812805del
NG_008690.1:g.27706_27710del
NG_008690.2:g.68514_68518del
NM_000277.1:c.190_194del
NM_000277.2:c.190_194del
NM_001354304.1:c.190_194del
ENST00000307000.7:c.175_179del
ENST00000546844.1:c.190_194del
ENST00000548677.2:n.277_281del
ENST00000548928.1:n.112_116del
ENST00000549111.5:n.286_290del
ENST00000550978.6:n.174_178del
ENST00000551337.5:c.190_194del
ENST00000551988.5:n.279_283del
ENST00000553106.5:c.190_194del
ENST00000635500.1:n.158_162del

Pathogenic

Met criteria codes 4
PM3 PM2 PVS1 PP4_Moderate

Evidence Links 1

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Phenylketonuria VCEP
The c.190_194delCACAT variant in PAH has been previously reported as a single variant, found in trans with the Likely Pathogenic (per internal PAH ClinGen Working Group classification -see PAH0095) p.Ala156Pro variant in a female Chinese proband with classic PKU (PM3) (PMID: 28754886); the authors report that BH4 deficiency was excluded by “analysis of urinary pterins and dihydropteridine reductase activity in erythrocytes” (PP4_Moderate) (PMID: 28754886). The sequence change results in a nonsense variant which occurs in exon 3 of 13 in the in the canonical transcript of PAH, a gene fulfilling the most recent criteria for LOF being a known disease mechanism (see PMID: 30192042) (PVS1). It is absent from control databases including ethnically matched individuals, including gnomAD/ExAC, 1000 Genomes, and ESP (PM2). In summary, this variant meets criteria to be classified as pathogenic for PAH. PAH-specific ACMG/AMP criteria applied: PVS1, PM2, PP4_Moderate, PM3.
Met criteria codes
PM3
The c.190_194delCACAT variant in PAH has been previously reported as a single variant, found in trans with the Likely Pathogenic (per internal PAH ClinGen Working Group classification -see PAH0095) p.Ala156Pro variant in a female Chinese proband with classic PKU (PM3) (PMID: 28754886)

PM2
It is absent from control databases including ethnically matched individuals, including gnomAD/ExAC, 1000 Genomes, and ESP (PM2).
PVS1
The sequence change results in a nonsense variant which occurs in exon 3 of 13 in the in the canonical transcript of PAH, a gene fulfilling the most recent criteria for LOF being a known disease mechanism (see PMID: 30192042) (PVS1).
PP4_Moderate
The c.190_194delCACAT variant in PAH has been previously reported as a single variant, found in trans with the Likely Pathogenic (per internal PAH ClinGen Working Group classification -see PAH0095) p.Ala156Pro variant in a female Chinese proband with classic PKU (PM3) (PMID: 28754886); the authors report that BH4 deficiency was excluded by “analysis of urinary pterins and dihydropteridine reductase activity in erythrocytes” (PP4_Moderate) (PMID: 28754886).

Approved on: 2019-04-04
Published on: 2019-08-16
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.